4/A
Changes in Ownership
AYTU BIOPHARMA, INC Filed Acc 0001209191-16-139751
Options or other derivatives
- Chief Executive Officer bought 250,000 shares
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Disbrow Joshua R. Chief Executive Officer | 2016-05-06 | Purchase · Warrant to Purchase Common Stock | +250,000 | 250,000 | D: show line 1 in the form |
Loading xslF345X03/doc4a.xml…